Phosphatidyl Inositol 3-Kinase (PI3K)-Inhibitor CDZ173 protects against LPS-induced osteolysis

Phosphatidyl Inositol 3-Kinase (PI3K)-Inhibitor CDZ173 protects against LPS-induced osteolysis

A major complication of a joint replacement is prosthesis loosening caused by inflammatory osteolysis, leading to the revision of the operation. This is due to the abnormal activation of osteoclast differentiation and function caused by periprosthetic infection. Therefore, targeting abnormally activ...

Full description

Bibliographic Details
Main Authors: Zuoxing Wu, Xuedong Li, Xiaohui Chen, Xuemei He, Yu Chen, Long Zhang, Zan Li, Mengyu Yang, Guixin Yuan, Baohong Shi, Ning Chen, Na Li, Haotian Feng, Mengyu Zhou, Gang Rui, Feng Xu, Ren Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pharmacology
Subjects:
Osteoclast
CDZ173
Osteolysis
PI3K
MAPK
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1021714/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1021714/full

Similar Items